Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Merck
AstraZeneca
Boehringer Ingelheim
Medtronic

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: duloxetine hydrochloride

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

duloxetine hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company 0002-3235-60 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3235-60)
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company 0002-3240-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3240-30)
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company 0002-3240-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3240-90)
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company 0002-3270-04 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3270-04)
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company 0002-3270-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3270-30)
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA PD-Rx Pharmaceuticals, Inc. 55289-028-21 21 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-028-21)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
McKesson
Harvard Business School
Baxter
Johnson and Johnson